HEPATITIS C
Clinical trials for HEPATITIS C explained in plain language.
Never miss a new study
Get alerted when new HEPATITIS C trials appear
Sign up with your email to follow new studies for HEPATITIS C, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Second chance: new trial aims to cure hepatitis c after first treatment fails
Disease control ENROLLING_BY_INVITATIONThis study is for people in Pakistan with hepatitis C whose first treatment didn't work. It compares two different medication plans to see which one clears the virus better. About 318 adults will take part, and the goal is to find a safe, effective second-line option.
Matched conditions: HEPATITIS C
Phase: NA • Sponsor: Queen Mary University of London • Aim: Disease control
Last updated May 26, 2026 05:06 UTC
-
Peer support boosts hepatitis c care for former inmates
Disease control OngoingThis study looks at whether a peer-based program can help people recently released from jail or prison get connected to Hepatitis C treatment and stay in care. About 80 participants with chronic Hepatitis C will be randomly assigned to receive the peer support program or standard…
Matched conditions: HEPATITIS C
Phase: NA • Sponsor: Montefiore Medical Center • Aim: Disease control
Last updated May 26, 2026 05:05 UTC
-
Can hepatitis c lungs be safely transplanted? pilot study explores new donor source
Disease control OngoingThis early-phase study tests whether lungs from hepatitis C positive donors can be safely transplanted into hepatitis C negative patients awaiting a lung transplant. The approach uses a special lung preservation machine (EVLP) to possibly reduce the virus, and if infection occurs…
Matched conditions: HEPATITIS C
Phase: EARLY_PHASE1 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated May 26, 2026 04:37 UTC
-
Hepatitis c kidneys safe for transplant? new trial tests antiviral protection
Disease control OngoingThis study tests whether kidneys from donors with hepatitis C (HCV) can be safely transplanted into patients who do not have HCV. After transplant, patients receive an antiviral drug (Epclusa) to prevent or treat any HCV infection. The goal is to expand the donor pool and reduce …
Matched conditions: HEPATITIS C
Phase: PHASE2 • Sponsor: Amit D Tevar, MD • Aim: Disease control
Last updated May 19, 2026 11:59 UTC
-
Hearts from hepatitis c donors could expand transplant options for patients in need
Disease control OngoingThis study tests whether hearts from donors with hepatitis C can be safely given to people without hepatitis C who need a heart transplant. Twenty adults with end-stage heart failure on the transplant waiting list will receive such hearts and be treated with antiviral medication …
Matched conditions: HEPATITIS C
Phase: PHASE2 • Sponsor: Mary E. Keebler, MD • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Breakthrough drug combo may stop hepatitis c spread in organ transplants
Prevention OngoingThis study tests whether a short course of two drugs (glecaprevir/pibrentasvir and ezetimibe) can prevent hepatitis C infection in people who receive a kidney, heart, lung, or pancreas from a hepatitis C-positive donor. About 200 participants who are hepatitis C-negative and awai…
Matched conditions: HEPATITIS C
Phase: PHASE4 • Sponsor: Mayo Clinic • Aim: Prevention
Last updated May 11, 2026 20:38 UTC